Apollo Hospitals announces partnership with TechEmerge to increase capacity to screen for cervical cancer at lower cost
New Delhi, March 7th, 2017: The Apollo Hospitals Enterprise Limited is proud
to announce its partnership with MobileODT that will apply its Enhanced
Visual Assessment (EVA) System to reduce loss of follow up for women who
screen positive on cervical cancer screening tests, and increase internal
capacity to screen for cervical cancer at a lower cost.
Cervical cancer kills 1 Indian every 7 minutes and more women die from
cervical cancer in India, than in any other country and it is preventable.
However, to be effective in reducing cervical cancer incidence and
mortality, screening programs must be of high quality. MobileODT's Enhanced
Visual Assessment (EVA) System, is a comprehensive point of care tool, built
on a smartphone, for cervical cancer screening. The device augments a
smartphone's optics to enable enhanced imaging while the app allows for
image and patient data capture for remote consultation.
Apollo Research and Innovations (ARI), a division of Apollo Hospitals has a
comprehensive ecosystem to undertake evaluation and validation of
Innovations in Healthcare. With the burden of cervical cancer, it is
important to have clarity on cervical cancer screening to get information
and actual data from the rural, semi-urban and urban areas to get the
realistic community data and perspective.
Seemant Jauhari, CEO - Research & Innovations, Apollo Hospitals said, "The
Indian healthcare landscape presents significant challenges related to
patient volumes access and affordability. Traditional healthcare delivery
models necessarily need to be disrupted by converging Technology with
healthcare. Mobile ODT is one such disruptive technology which shall
facilitate taking cervical screening to the people of India, enable early
screening and hence early treatment thus slowing down incidences of cervical
cancer. It maximises the chances of making cervical cancer screening
"India is home to 1/3 of all cervical cancer deaths worldwide. We are
honoured to be working with Apollo Hospitals given its focus on quality,
innovative, and patient centred care to tackle this large, but preventable
challenge women face across all of India. We hope this partnership continues
to expand, to ensure all Apollo patients have quality cervical cancer
screening from the smallest rural clinic and telemedicine efforts to the
large urban centres." said Ariel Beery, CEO, MobileODT.
Mobile ODT EVA system has been piloted around the world (namely in Haiti,
Guatemala, Botswana, Kenya, Nepal, Mexico, Kenya, United States) before the
collaboration with Apollo Hospitals. It is important to pilot the device
over 5 sites to understand the efficacy, utility and usability of the
technology. The sites chosen cover rural area (Aragonda), semi-urban (Apollo
Vanagaram, Apollo Madurai), urban (Apollo First Med, Apollo Tondiarpet) and
high income group (Bangalore). With the presence of Apollo Hospital centres
in all the areas, Apollo Research and Innovations (ARI) is in a position to
give the public data, rather than restricting to only a regional data.
Apollo Hospitals Enterprise Limited with MobileODT was selected from 330
companies to apply the life-saving technology in India through TechEmerge,
which matches technology companies around the world with partners in
emerging markets to deliver tools that improve quality of life. As a result
of the rigorous process, with advisors from IFC and Health 2.0 part of the
design, MobileODT is launching new pilots with Apollo Hospitals and
Apollo Research and Innovations (ARI) is a department of Apollo Hospitals Enterprise Ltd. spearheading research, innovations and educational related programs in quest of enabling Apollo Hospitals to introduce cutting edge technologies, therapies and other innovations in its ecosystem.